Could a lower dose of stroke drug be safer for seniors?
Disease control
Recruiting now
This study is testing whether a lower dose of the clot-busting drug tenecteplase is safer and just as effective as the standard dose for treating acute ischemic stroke in people aged 70 and older. About 798 participants will receive either a low dose (0.175 mg/kg) or the standard…
Phase: PHASE4 • Sponsor: Southwest Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC